MYD88 and diffuse large B-cell lymphoma: Recently, oncogenic MyD88 mutations, such as L265P (discussed in Section 2), have been shown to induce the activation of NIK and thus increase processing of p100 and p105 in DLBCL (Figure 4b) [174].